2003, the National Breast Cancer Center * conducted a survey, 3,000 women, aged between 30 to 69 years old. Investigation of women's knowledge, attitudes and behaviour of breast cancer.
The survey found that there are many things the confusion may increase women's access to breast cancer, known as risk factors.
The investigation showed that many females did not know you the woman contracts breast cancer's danger to increase, because you age. It also disclosed that many women did not know drinks wine to be possible to increase your risk with the overload.
On the other hand, many women mistakenly believe a bump or knock to the breast increases your risk of breast cancer, when the research does not support this claim.
It is important to separate the fact from the fiction about risk factors for breast cancer. With an understanding of the things that may increase your chance of developing breast cancer, you can take positive steps to reduce your risk.
I am increasing the woman to contract breast cancer's danger? As a result of these survey result, national breast cancer center * dwell upon research, to breast cancer hazard factor.
From this information we developed Your risk and breast cancer, an online information resource and calculator. With these resources we aim to inform women and help individuals to understand their level of risk for breast cancer.
Answers the question, in the calculator, you will be able to calculate your current risk.
Please note that the risk calculator is designed for use by women who are not breast cancer or ovarian cancer. National breast cancer and ovarian cancer are the center of a web site devoted to breast cancer in men, which sets out in detail the risk factors for men.
The Italian study switched women taking the tamoxifen therapy to the aromatase inhibitor 2 to 3 years into the normal 5 year regiment. According to the results, there was improved performance of the aromatase inhibitors. This means that not only is it more efficient at fighting cancer, it will also allow users to avoid the adverse side affects such as endometrial cancer and strokes created by the other medication
This was a large study and it backs up other reports which also seem to show a benefit from Raloxifene in terms of breast cancer in women after the menopause. The latter point here may be important - after the menopause.
But is there a place for the medication in the prevention of new breast cancer cases? That answer still remains elusive so we don't know if it should be given to healthy women as a way of reducing breast cancer risk.
Although this medication may go on to save the lives of many women, the FDA should not allow companies who have interest in the outcome of the study be the one who funds and conducts it. Anyone who has interest in the outcome of any event will always do what is in their power to protect their interest. Like the old adage goes. ?You ain't cheatin, You ain't tryin .?
Both Darlene Yocom & Ray Lam are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Darlene Yocom has sinced written about articles on various topics from Types of Cancer. . Darlene Yocom's top article generates over 1900 views. to your Favourites.
Ray Lam has sinced written about articles on various topics from Family, Free Credit Report Score and Air Purifier Cleaners. Learn about and get a limited FREE report on Latest Breast Cancer Drugs by visiting. Ray Lam's top article generates over 246000 views. to your Favourites.